813 related articles for article (PubMed ID: 14974359)
1. [Influence of erythropoietin on immunological system of patients with chronic renal failure].
Debska-Slizień A; Rutkowski B; Manitius J; Zdrojewski Z; Szołkiewicz M; Bułło B; Lizakowski S; Myśliwska J; Myśliwski A; Bryl E; Trzonkowski P; Bakowska A; Rachoń D
Pol Merkur Lekarski; 2003 Oct; 15(88):326-7; discussion 327-9. PubMed ID: 14974359
[TBL] [Abstract][Full Text] [Related]
2. Long-term therapy with recombinant human erythropoietin decreases percentage of CD152(+) lymphocytes in primary glomerulonephritis haemodialysis patients.
Trzonkowski P; Myśliwska J; Debska-Slizień A; Bryl E; Rachoń D; Myśliwski A; Rutkowski B
Nephrol Dial Transplant; 2002 Jun; 17(6):1070-80. PubMed ID: 12032199
[TBL] [Abstract][Full Text] [Related]
3. Effect of iron loading on peripheral blood lymphocyte subsets and on circulating cytokine levels in iron-depleted hemodialysis patients receiving erythropoietin.
Tsouchnikas I; Tsilipakou M; Daniilidis M; Kyriazis G; Pasadakis P; Parapanissiou E; Vargemezis V; Tsakiris D
Nephron Clin Pract; 2007; 107(3):c97-102. PubMed ID: 17890877
[TBL] [Abstract][Full Text] [Related]
4. T-cell function, T-cell phenotype and its role in responsiveness to recombinant human erythropoietin in hemodialysis patients.
Abdalla M; Yassein S; Darwish KH
Egypt J Immunol; 2010; 17(2):67-80. PubMed ID: 23082488
[TBL] [Abstract][Full Text] [Related]
5. The effects of peritoneal dialysis and hemodialysis on serum tumor necrosis factor-alpha, interleukin-6, interleukin-10 and C-reactive-protein levels.
Borazan A; Ustün H; Ustundag Y; Aydemir S; Bayraktaroglu T; Sert M; Yilmaz A
Mediators Inflamm; 2004 Jun; 13(3):201-4. PubMed ID: 15223612
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis during treatment with infliximab.
Zou J; Rudwaleit M; Brandt J; Thiel A; Braun J; Sieper J
Arthritis Rheum; 2003 Mar; 48(3):780-90. PubMed ID: 12632433
[TBL] [Abstract][Full Text] [Related]
7. [Cytokines in children with immunodeficiencies].
Kowalczyk D
Folia Med Cracov; 1999; 40(1-2):5-97. PubMed ID: 10909468
[TBL] [Abstract][Full Text] [Related]
8. [Guidelines for the treatment of anemia in chronic renal failure].
Triolo G;
G Ital Nefrol; 2003; 20 Suppl 24():S61-82. PubMed ID: 14666504
[TBL] [Abstract][Full Text] [Related]
9. Body fat mass and serum leptin levels influence epoetin sensitivity in patients with ESRD.
Axelsson J; Qureshi AR; Heimbürger O; Lindholm B; Stenvinkel P; Bárány P
Am J Kidney Dis; 2005 Oct; 46(4):628-34. PubMed ID: 16183417
[TBL] [Abstract][Full Text] [Related]
10. Analysis of peripheral blood T-cell subsets, natural killer cells and serum levels of cytokines in children with Down syndrome.
Cetiner S; Demirhan O; Inal TC; Tastemir D; Sertdemir Y
Int J Immunogenet; 2010 Aug; 37(4):233-7. PubMed ID: 20477881
[TBL] [Abstract][Full Text] [Related]
11. PAF-acetylhydrolase activity in plasma of patients with chronic kidney disease. Effect of long-term therapy with erythropoietin.
Papavasiliou EC; Gouva C; Siamopoulos KC; Tselepis AD
Nephrol Dial Transplant; 2006 May; 21(5):1270-7. PubMed ID: 16421163
[TBL] [Abstract][Full Text] [Related]
12. [Tuberculosis in compromised hosts].
Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
[TBL] [Abstract][Full Text] [Related]
13. Beta blocker and angiotensin-converting enzyme inhibitor therapy is associated with decreased Th1/Th2 cytokine ratios and inflammatory cytokine production in patients with chronic heart failure.
Gage JR; Fonarow G; Hamilton M; Widawski M; Martínez-Maza O; Vredevoe DL
Neuroimmunomodulation; 2004; 11(3):173-80. PubMed ID: 15067208
[TBL] [Abstract][Full Text] [Related]
14. Long-term therapy with recombinant human erythropoietin increases CD8+ T-cell apoptosis in haemodialysis patients.
Trzonkowski P; Debska-Slizien A; Szmit E; Myśliwska J; Szymańska K; Hak Ł; Myśliwski A; Rutkowski B
Nephrol Dial Transplant; 2005 Feb; 20(2):367-76. PubMed ID: 15585513
[TBL] [Abstract][Full Text] [Related]
15. Blood serum levels of IL-2, IL-6, IL-8, TNF-alpha and IL-1beta in patients on maintenance hemodialysis.
Rysz J; Banach M; Cialkowska-Rysz A; Stolarek R; Barylski M; Drozdz J; Okonski P
Cell Mol Immunol; 2006 Apr; 3(2):151-4. PubMed ID: 16696903
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human erythropoietin resistance in hemodialysis. Effects of paired filtration dialysis.
Carozzi S; Nasini MG; Santoni O; Tirotta A; Sanna A
ASAIO J; 1997; 43(5):M535-8. PubMed ID: 9360100
[TBL] [Abstract][Full Text] [Related]
17. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.
Woolley DE; Tetlow LC
Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory mediators and immune function are altered in home parenteral nutrition patients.
Hise ME; Compher C; Harlan L; Kohlmeier JE; Benedict SH; Gajewski B; Brown JC
Nutrition; 2006 Feb; 22(2):97-103. PubMed ID: 16459221
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human erythropoietin treatment of chronic renal failure patients normalizes altered phenotype and proliferation of CD4-positive T lymphocytes.
Lisowska KA; Debska-Slizien A; Radzka M; Witkowski JM; Rutkowski B; Bryl E
Artif Organs; 2010 Mar; 34(3):E77-84. PubMed ID: 20447038
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
Smith WB; Dowell JA; Pratt RD
Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
